Intensity Therapeutics Statistics

Total Valuation

INTS has a market cap or net worth of $8.02 million. The enterprise value is $7.23 million.

Market Cap	8.02M
Enterprise Value	7.23M

Important Dates

The next estimated earnings date is Thursday, August 7, 2025, after market close.

Earnings Date	Aug 7, 2025
Ex-Dividend Date	n/a

Share Statistics

INTS has 25.07 million shares outstanding. The number of shares has increased by 27.54% in one year.

Current Share Class	25.07M
Shares Outstanding	25.07M
Shares Change (YoY)	+27.54%
Shares Change (QoQ)	+5.36%
Owned by Insiders (%)	13.82%
Owned by Institutions (%)	10.40%
Float	18.92M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	14.58
P/TBV Ratio	24.02
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 0.63, with a Debt / Equity ratio of 0.39.

Current Ratio	0.63
Quick Ratio	0.35
Debt / Equity	0.39
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -298.57% and return on invested capital (ROIC) is -184.12%.

Return on Equity (ROE)	-298.57%
Return on Assets (ROA)	-123.09%
Return on Invested Capital (ROIC)	-184.12%
Return on Capital Employed (ROCE)	-3,494.50%
Revenue Per Employee	n/a
Profits Per Employee	-$2.14M
Employee Count	7
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -93.51% in the last 52 weeks. The beta is 4.32, so INTS's price volatility has been higher than the market average.

Beta (5Y)	4.32
52-Week Price Change	-93.51%
50-Day Moving Average	0.59
200-Day Moving Average	2.15
Relative Strength Index (RSI)	38.74
Average Volume (20 Days)	2,703,082

Short Selling Information

The latest short interest is 659,567, so 2.63% of the outstanding shares have been sold short.

Short Interest	659,567
Short Previous Month	461,635
Short % of Shares Out	2.63%
Short % of Float	3.49%
Short Ratio (days to cover)	0.30

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-15.24M
Pretax Income	-15.07M
Net Income	-15.01M
EBITDA	n/a
EBIT	-15.24M
Earnings Per Share (EPS)	-$1.05

Full Income Statement

Balance Sheet

The company has $929,000 in cash and $131,000 in debt, giving a net cash position of $798,000 or $0.03 per share.

Cash & Cash Equivalents	929,000
Total Debt	131,000
Net Cash	798,000
Net Cash Per Share	$0.03
Equity (Book Value)	334,000
Book Value Per Share	0.02
Working Capital	-978,000

Full Balance Sheet

Cash Flow

Operating Cash Flow	-12.84M
Capital Expenditures	n/a
Free Cash Flow	n/a
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

INTS does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-27.54%
Shareholder Yield	-27.54%
Earnings Yield	-187.10%
FCF Yield	n/a

Analyst Forecast

The average price target for INTS is $8.50, which is 2,556.25% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$8.50
Price Target Difference	2,556.25%
Analyst Consensus	Strong Buy
Analyst Count	3
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	1